Strong Q3 Performance and Future Growth Prospects Justify Buy Rating on Sarepta Therapeutics
William Blair analyst Sami Corwin has maintained their bullish stance on SRPT stock, giving a Buy rating today. Sami Corwin’s rating is ...
Vaxcyte’s Strong Market Position and Financial Health Justify Buy Rating with $153 Target
Leerink Partners analyst David Risinger reiterated a Buy rating on Vaxcyte (PCVX – Research Report) on November 5 and set a price target ...
Sprouts Farmers Market: Buy This Aggressive Acceleration
Sprouts Farmers Market’s plan to achieve 10%+ unit growth annually, focusing on the West Coast, Texas, and the Northeast.
Apple's Services And Silicon Strategy To Fuel Margins, Justify High Valuation: Analyst
BofA Securities analyst Wamsi Mohan maintained a Buy rating on Apple Inc (NASDAQ:AAPL) with a price target of $256. The ...
Crooks and Liars13h
America Chose Violence
There is a violence perpetrated on us all by that decision. Multiply it by several thousand in every swing state and it ...
Hosted on MSN6d
I’m in my mid-30s and have banked millions – I want to buy a sports car but just can’t justify the purchase
Do you really need that fancy sports car? Questions like this one plague all of us when we find ourselves with any amount of ...
Should You Buy Palantir Stock Before Monday's News? 2 Critical Things Investors Need to Know.
The release is highly anticipated as investors are keen to see its revenue growth continue apace. So, should you buy Palantir ...
Edenred: Q3 Decline Does Not Make Sense To Me - I Say 'Buy'
Read why I remain bullish on Edenred despite the recent drop, citing strong fundamentals, undervaluation, and growth ...
Fortune on MSN5d
Nvidia’s stock performance has been ‘staggering.’ But recent buyers of the stock are taking a far greater risk than they realize
A close look at the data suggests long-term investors who buy Nvidia stock at recent prices are unlikely to get the returns ...
3 Dividend Stocks That Could Raise Their Payouts in November
For buy-and-hold investors, Merck is a stock that could hold a ... Today, the stock pays its investors 3%, and there's plenty of room for the company to justify another raise, given its fairly low ...
Arm’s 90% Rally Shines Light on High Multiple, Low Growth
Arm shares trade at more than 76 times estimated earnings, making it the third-most expensive stock in the Nasdaq 100 by this ...
Racing Post1d
Mandy Pope prevails at Keeneland to land Roses For Debra at $2.4 million
Roses For Debra captured the attention at the Keeneland November SaleCredit: Keeneland photo Mandy Pope's Whisper Hill Farm landed the day's top-selling mare during Tuesday's opening session of the ...